禾伸堂在美癌症研究年會 發布CA102N新藥 - 股票

By George
at 2020-07-16T15:50
at 2020-07-16T15:50
Table of Contents
1.原文連結:
https://www.chinatimes.com/newspapers/20200715000435-260202?chdtv
2.原文內容:
禾伸堂在美癌症研究年會 發布CA102N新藥實驗
禾伸堂生技的大腸直腸癌抗癌新藥(簡稱:CA102N)於美國癌症研究協會年會會議(
AACR Virtual Annual Meeting Ⅱ)中,由安德森癌症中心(MD Anderson Cancer
Center)與禾伸堂生技共同發表CA102N透過抑制PI3K路徑及免疫調節機制抑制實驗結果。
目前實驗結果顯示,CA102N經由抑制腫瘤內PI3K相關路徑對CT26小鼠大腸癌腫瘤產生顯著
的生長抑制效果,同時可顯著降低腫瘤內發炎因子PGE2及PGI2,以及降低血液中IL-6與
MCP-1發炎細胞因子。另外,CA102N可降低腫瘤FOXP3+ T-regulatory細胞並且提高CD8
+ T-cell,藉由上述降低發炎因子及免疫調節作用,進一步提高其抑制腫瘤生長之能力
。
禾伸堂指出,CA102N是利用透明質酸作為抗癌藥物載體的標靶治療藥物,藉由透明質酸共
軛鍵結藥物技術,將透明質酸與癌細胞表面的特徵接受器Cluster of differentiation
44(CD44)產生系統性的交互作用後,讓透明質酸鍵結之藥物遞送到癌細胞內部,CA102N
其抑癌機轉為抑制PI3K/Akt/mTOR相關路徑,並誘導細胞凋亡與抑制血管新生,具免疫
治療潛力,目前已在美國進行第一期人體臨床實驗,未來不排除還可擴及其它癌症的治療
。
3.心得/評論:
就在新藥股大幅回檔的情況下
今天禾伸堂呈現貼息
如果能早一點搭上順風車的話
--
https://www.chinatimes.com/newspapers/20200715000435-260202?chdtv
2.原文內容:
禾伸堂在美癌症研究年會 發布CA102N新藥實驗
禾伸堂生技的大腸直腸癌抗癌新藥(簡稱:CA102N)於美國癌症研究協會年會會議(
AACR Virtual Annual Meeting Ⅱ)中,由安德森癌症中心(MD Anderson Cancer
Center)與禾伸堂生技共同發表CA102N透過抑制PI3K路徑及免疫調節機制抑制實驗結果。
目前實驗結果顯示,CA102N經由抑制腫瘤內PI3K相關路徑對CT26小鼠大腸癌腫瘤產生顯著
的生長抑制效果,同時可顯著降低腫瘤內發炎因子PGE2及PGI2,以及降低血液中IL-6與
MCP-1發炎細胞因子。另外,CA102N可降低腫瘤FOXP3+ T-regulatory細胞並且提高CD8
+ T-cell,藉由上述降低發炎因子及免疫調節作用,進一步提高其抑制腫瘤生長之能力
。
禾伸堂指出,CA102N是利用透明質酸作為抗癌藥物載體的標靶治療藥物,藉由透明質酸共
軛鍵結藥物技術,將透明質酸與癌細胞表面的特徵接受器Cluster of differentiation
44(CD44)產生系統性的交互作用後,讓透明質酸鍵結之藥物遞送到癌細胞內部,CA102N
其抑癌機轉為抑制PI3K/Akt/mTOR相關路徑,並誘導細胞凋亡與抑制血管新生,具免疫
治療潛力,目前已在美國進行第一期人體臨床實驗,未來不排除還可擴及其它癌症的治療
。
3.心得/評論:
就在新藥股大幅回檔的情況下
今天禾伸堂呈現貼息
如果能早一點搭上順風車的話
--
Tags:
股票
All Comments

By Tom
at 2020-07-19T01:35
at 2020-07-19T01:35

By Kumar
at 2020-07-20T09:56
at 2020-07-20T09:56

By Megan
at 2020-07-24T08:40
at 2020-07-24T08:40

By Kumar
at 2020-07-28T23:03
at 2020-07-28T23:03

By Hedy
at 2020-07-31T19:09
at 2020-07-31T19:09

By David
at 2020-08-03T16:13
at 2020-08-03T16:13

By Christine
at 2020-08-07T12:42
at 2020-08-07T12:42

By Gary
at 2020-08-08T20:49
at 2020-08-08T20:49

By Dora
at 2020-08-12T05:23
at 2020-08-12T05:23

By Puput
at 2020-08-14T23:34
at 2020-08-14T23:34

By Noah
at 2020-08-19T14:09
at 2020-08-19T14:09

By Connor
at 2020-08-22T18:58
at 2020-08-22T18:58

By Bethany
at 2020-08-23T18:33
at 2020-08-23T18:33

By Hardy
at 2020-08-25T00:15
at 2020-08-25T00:15

By Zora
at 2020-08-28T22:55
at 2020-08-28T22:55

By Hamiltion
at 2020-08-31T01:54
at 2020-08-31T01:54

By Ivy
at 2020-09-03T02:10
at 2020-09-03T02:10

By Kama
at 2020-09-06T16:54
at 2020-09-06T16:54

By Wallis
at 2020-09-09T23:41
at 2020-09-09T23:41

By Skylar Davis
at 2020-09-13T05:40
at 2020-09-13T05:40

By Mia
at 2020-09-17T11:35
at 2020-09-17T11:35

By Carolina Franco
at 2020-09-21T02:42
at 2020-09-21T02:42

By Oliver
at 2020-09-24T06:30
at 2020-09-24T06:30

By Blanche
at 2020-09-28T08:55
at 2020-09-28T08:55

By Liam
at 2020-09-30T21:18
at 2020-09-30T21:18

By Elizabeth
at 2020-10-05T02:11
at 2020-10-05T02:11

By George
at 2020-10-09T09:02
at 2020-10-09T09:02

By Mia
at 2020-10-14T03:50
at 2020-10-14T03:50

By Lily
at 2020-10-16T01:04
at 2020-10-16T01:04

By Franklin
at 2020-10-16T10:33
at 2020-10-16T10:33

By Irma
at 2020-10-16T11:55
at 2020-10-16T11:55

By Damian
at 2020-10-19T15:15
at 2020-10-19T15:15

By Wallis
at 2020-10-23T03:29
at 2020-10-23T03:29

By Callum
at 2020-10-28T01:23
at 2020-10-28T01:23

By Ivy
at 2020-10-30T14:44
at 2020-10-30T14:44

By Quintina
at 2020-11-04T09:53
at 2020-11-04T09:53

By Sarah
at 2020-11-09T06:09
at 2020-11-09T06:09

By Valerie
at 2020-11-10T17:19
at 2020-11-10T17:19

By Hazel
at 2020-11-15T07:26
at 2020-11-15T07:26

By Lily
at 2020-11-15T19:19
at 2020-11-15T19:19

By Odelette
at 2020-11-17T18:47
at 2020-11-17T18:47

By Carolina Franco
at 2020-11-20T08:30
at 2020-11-20T08:30

By Ivy
at 2020-11-24T18:10
at 2020-11-24T18:10

By Damian
at 2020-11-27T19:38
at 2020-11-27T19:38

By Kama
at 2020-11-29T17:01
at 2020-11-29T17:01

By Olive
at 2020-12-02T03:30
at 2020-12-02T03:30

By Kama
at 2020-12-03T07:25
at 2020-12-03T07:25

By Annie
at 2020-12-06T13:56
at 2020-12-06T13:56

By Ophelia
at 2020-12-08T06:19
at 2020-12-08T06:19

By Elma
at 2020-12-08T23:15
at 2020-12-08T23:15

By Ina
at 2020-12-10T06:56
at 2020-12-10T06:56

By Elvira
at 2020-12-13T07:45
at 2020-12-13T07:45

By Dora
at 2020-12-15T03:04
at 2020-12-15T03:04

By Isabella
at 2020-12-18T14:25
at 2020-12-18T14:25

By Blanche
at 2020-12-20T13:52
at 2020-12-20T13:52

By Ursula
at 2020-12-23T09:14
at 2020-12-23T09:14

By Kumar
at 2020-12-26T05:30
at 2020-12-26T05:30

By Valerie
at 2020-12-31T01:17
at 2020-12-31T01:17

By David
at 2021-01-01T02:40
at 2021-01-01T02:40

By Dorothy
at 2021-01-02T09:51
at 2021-01-02T09:51

By Damian
at 2021-01-07T03:51
at 2021-01-07T03:51

By Ethan
at 2021-01-08T06:12
at 2021-01-08T06:12

By Annie
at 2021-01-10T21:28
at 2021-01-10T21:28

By Zora
at 2021-01-14T20:09
at 2021-01-14T20:09

By Joseph
at 2021-01-15T15:05
at 2021-01-15T15:05

By Emily
at 2021-01-19T21:22
at 2021-01-19T21:22

By Megan
at 2021-01-21T21:53
at 2021-01-21T21:53

By Jacob
at 2021-01-25T04:10
at 2021-01-25T04:10

By Hedwig
at 2021-01-29T09:06
at 2021-01-29T09:06

By Eden
at 2021-01-30T19:01
at 2021-01-30T19:01

By Hardy
at 2021-02-04T13:52
at 2021-02-04T13:52

By Genevieve
at 2021-02-09T05:18
at 2021-02-09T05:18

By Connor
at 2021-02-11T16:50
at 2021-02-11T16:50
Related Posts
合一(4743)短多

By Margaret
at 2020-07-16T15:36
at 2020-07-16T15:36
全球半導體行業併購熱潮回溫了嗎?

By Carolina Franco
at 2020-07-16T15:34
at 2020-07-16T15:34
合一吞第4根跌停板 上櫃生技指數重摔

By Tom
at 2020-07-16T15:33
at 2020-07-16T15:33
台積電營收創新高

By Emily
at 2020-07-16T15:20
at 2020-07-16T15:20
109年07月16日 三大法人買賣金額統計表

By Margaret
at 2020-07-16T15:06
at 2020-07-16T15:06